What does Washington Senate Bill SB 5594 do?

SB 5594: Concerning biosimilar medicines.

When was Washington Senate Bill SB 5594 introduced?

SB 5594 was introduced on Jan 30, 2025.

Yes, SB 5594 has passed the Senate on Mar 11, 2025.

SB 5594 was introduced by Paul Harris.

Yes, there is one legislator voting record available for SB 5594

SB 5594

Washington Senate Bill

Concerning biosimilar medicines.

House • Apr 01, 2025: Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM.

Engrossed Substitute

Type in some keywords and press enter:

Sponsors

Votes

Actions

Apr 01, 2025 | House
- Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM.
Mar 26, 2025 | House
- Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
Mar 13, 2025 | House
- First reading, referred to Health Care & Wellness.
Mar 11, 2025 | Senate
- 1st substitute bill substituted (HLTC 25).
- Floor amendment(s) adopted.
- Rules suspended. Placed on Third Reading.
- Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
Mar 05, 2025 | Senate
- Placed on second reading by Rules Committee.
Feb 19, 2025 | Senate
- Passed to Rules Committee for second reading.
Feb 18, 2025 | Senate
- Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM.
- HLTC - Majority; 1st substitute bill be substituted, do pass.
Feb 11, 2025 | Senate
- Public hearing in the Senate Committee on Health & Long-Term Care at 10:30 AM.
Jan 30, 2025 | Senate
- First reading, referred to Health & Long-Term Care.

Bill Texts

Documents

Sources